Genex Corp said it hascompleted an agreement for Eberstadt Fleming Venture Capital'sPlant Resources Venture Fund II and Morgenthaler VenturePartners II and accounts managed by Citicorp &lt;CCI> to provideit with a four mln dlr interim credit line.    It said the Eberstadt venture capital funds and theCiticorp accounts will receive warrants to buy 1,666,667 commonshares at 60 cts each and two representatives of the funds willbe named to the Genex board.    Genex said as part of the transaction, it has signed anemplopyment agreement for a senior executive it did not name tobecome president and chief executive officer of Genex at theend of March, on completion of his obligations to his currentemployer.    The company said over the next six months, it will use itsbest efforts to increase its authorized capital and make a sixto eight mln dlr rights offering to holders of its convertiblepreferred stock at 60 cts per equivalent common share, withproceeds to be used to repay sums drawn from the interim lineof credit and for working capital.    Genex said the rights would not be transferable separatelyfrom the common stock.    It said its three largest shareholders, Robert F. Johnston,Koppers Co &lt;KOP> and J. Leslie Glick, who together own about 34pct of Genex stock, will provide irrevocable proxies to theventure firms on completion of the rights offering and haveagreed not to exercise their rights to acquire stock in therights offering.    Genex said the venture firms will have the right to buy anyunsubscribed shares of convertible preferred and may buyadditional shares at the time of the rights offer. Reuter&#3;